Arcutis Biotherapeutics (ARQT) Payables (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Payables of $18.3 million for Q1 2026, down 25.41% year-over-year from $24.5 million in Q1 2025, and up 46.04% quarter-over-quarter from $12.5 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Payables (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Payables history runs 8 years deep, the most recent figure standing at $18.3 million for Q1 2026.
- In Q1 2026, Payables fell 25.41% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $18.3 million (down 25.41% YoY), while the FY2025 annual figure was $12.5 million, down 11.9% from the prior year.
- Payables for Q1 2026 stood at $18.3 million, up from $12.5 million in the prior quarter.
- The five-year high for Payables was $24.5 million in Q1 2025, with the low at $5.8 million in Q3 2025.
- The 5-year median for Payables is $12.5 million (2025), against an average of $13.2 million.
- The sharpest annual moves came in 2022 and 2025: Payables surged 296.25% in 2022, then tumbled 70.01% in 2025.
- Arcutis Biotherapeutics' Payables stood at $8.8 million in 2022, then surged by 35.86% to $12.0 million in 2023, then rose by 18.58% to $14.2 million in 2024, then fell by 11.9% to $12.5 million in 2025, then jumped by 46.04% to $18.3 million in 2026.
- Business Quant data shows ARQT's Payables at $18.3 million in Q1 2026, $12.5 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 6.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.60 Mn |
| Mar 31, 2026 | 18.30 Mn |
| Dec 31, 2025 | 12.53 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 15.08 Mn |
| Mar 31, 2025 | 24.53 Mn |
| Dec 31, 2024 | 14.22 Mn |
| Sep 30, 2024 | 19.33 Mn |
| Jun 30, 2024 | 7.94 Mn |
| Mar 31, 2024 | 12.97 Mn |
| Dec 31, 2023 | 11.99 Mn |
| Sep 30, 2023 | 13.18 Mn |
| Jun 30, 2023 | 17.16 Mn |
| Mar 31, 2023 | 12.49 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Sep 30, 2022 | 8.67 Mn |
| Jun 30, 2022 | 8.44 Mn |
| Mar 31, 2022 | 12.47 Mn |
| Dec 31, 2021 | 7.35 Mn |
| Sep 30, 2021 | 4.87 Mn |